AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $982 | -10.0% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,091 | +146.3% | 40,000 | +100.0% | 0.00% | +100.0% |
| Q1 2023 | $443 | -18.3% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $542 | -99.9% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $568,000 | +29.4% | 20,000 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $439,000 | +367.0% | 20,000 | +614.3% | 0.00% | – |
| Q4 2021 | $94,000 | -94.4% | 2,800 | -92.4% | 0.00% | -100.0% |
| Q3 2021 | $1,688,000 | -13.2% | 36,700 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $1,944,000 | +8.0% | 36,700 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,800,000 | +20.6% | 36,700 | +8.3% | 0.01% | 0.0% |
| Q4 2020 | $1,492,000 | +23.7% | 33,900 | -4.8% | 0.01% | +20.0% |
| Q3 2020 | $1,206,000 | +743.4% | 35,600 | +1093.8% | 0.01% | +400.0% |
| Q4 2019 | $143,000 | – | 2,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |